PDCD1 and neoplasm: Liposomes and nanoparticles have been utilized to transport agents like anti-programmed cell death protein-1 (PD-1), anti-PD-L1, and anti-cytotoxic T-lymphocyte-associated protein-4, improving their tumor localization and enhancing therapeutic results [225].